BBIO - BridgeBio Pharma, Inc.
64.53
-0.970 -1.503%
Share volume: 2,315,849
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$65.50
-0.97
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-01-2024 | 11-12-2024 | 02-20-2025 | 04-29-2025 | 08-05-2025 | 10-29-2025 | 02-24-2026 | |
| Total revenue | 211.120 M | 2.168 M | 2.732 M | 5.882 M | 116.633 M | 110.565 M | 120.700 M | 154.178 M | |
| Cost of revenue | 598.000 K | 598.000 K | 598.000 K | 2.084 M | 2.639 M | 3.653 M | 6.563 M | 8.107 M | |
| Gross profit | 210.522 M | 1.570 M | 2.134 M | 3.798 M | 113.994 M | 106.912 M | 114.137 M | 146.071 M | |
| -99.25% | 35.92% | 77.98% | 2,901.42% | -6.21% | 6.76% | 27.98% | |||
| Operating expenses | 206.779 M | 174.218 M | 189.263 M | 225.132 M | 217.796 M | 240.385 M | 250.495 M | 274.502 M | |
| Selling general and admin | 65.807 M | 59.523 M | 68.819 M | 94.782 M | 106.365 M | 129.154 M | 137.621 M | 158.085 M | |
| Research and development | 140.972 M | 114.695 M | 120.444 M | 130.350 M | 111.431 M | 111.231 M | 112.874 M | 116.417 M | |
| Total expenses | 210.179 M | 177.109 M | 193.884 M | 229.825 M | 218.366 M | 241.190 M | 259.336 M | 285.633 M | |
| -15.73% | 9.47% | 18.54% | -4.99% | 10.45% | 7.52% | 10.14% | |||
| Operating income | 343.000 K | -175.539 M | -191.750 M | -226.027 M | -104.372 M | -134.278 M | -145.199 M | -139.562 M | |
| Ebit | 9.826 M | -176.171 M | -189.953 M | -224.403 M | -96.141 M | -127.730 M | -128.738 M | -127.744 M | |
| Pretax income | -36.160 M | -75.544 M | -164.254 M | -266.236 M | -169.608 M | -181.658 M | -186.482 M | -194.755 M | |
| 108.92% | 117.43% | 62.09% | -36.29% | 7.10% | 2.66% | 4.44% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 2.100 M | -1.545 M | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -36.160 M | -75.544 M | -164.254 M | -267.389 M | -169.608 M | -183.758 M | -184.937 M | -194.635 M | |
| -108.92% | -117.43% | -62.79% | 36.57% | -8.34% | -0.64% | -5.24% |